LibraryCommunityProductPricingDevelopers

Start free Live demo

Laboratory Exchange Surveillance Epidemiology Intelligence

Allyson:

Request a Demo

See Salus in your laboratory's context.

Tell us a little about your laboratory and we'll arrange a personalized demonstration.

Full name

Work email

Organization

Role

What would you like to see?

1

Live AI persona

8

Patents in Preparation

17

Languages Supported

100%

Human-supervised AI

PostgreSQL

Hosted lab data

Continuous adaptation for public health laboratory systems. Living intelligence, coded test content, and human-supervised agents under a 501(c)(3) access program.

Intelligence

How it works
Regulatory intelligence
Pathogen library
Agentic workbench
Integrity and attestation
Community registry
CDC DMI and TEFCA
Grant reporting
Genomics and WHO

Product

Features matrix
Overview
AI Personas
Technology
Access Program

Solutions

State Public Health
County Laboratories
Newborn Screening
Founding Laboratory Program

Programs

Public Health Access
Procurement & Funding
Governance
Founding Stewards
Professional Services
Integration Partners

Company

About
Resources
Learn
Contact

SOC 2 Type 1· December 2026SOC 2 Type 2· January 2027HIPAA· January 2027HITRUST r1· March 2027NIST CSF· alignedNIST SP 800-53· alignedHL7 v2 / FHIRLOINC / SNOMED CT

SOC 2 Type 1 is targeted for December 2026. SOC 2 Type 2 is targeted for January 2027. HIPAA is targeted for January 2027. HITRUST r1 has started, and completion is targeted for March 2027. The examinations are in progress under JIL Sovereign Technologies, Inc. (Delaware) with Johanson Group LLP. The reports are not issued. Salus does not claim a FedRAMP or StateRAMP authorization.

Operated by JIL Sovereign Technologies, Inc. salusagentic.com is part of JIL Sovereign Technologies, Inc., a Delaware corporation. SalusAgentic is a trade name of that company. JIL Sovereign Holdings, LLC (WY) owns the SalusAgentic software. Global Hands, Inc. (TX) gave a grant to JIL Sovereign Holdings, LLC (WY) to build salusagentic.com under its public good initiative. The cost to build SalusAgentic was greater than what Global Hands paid. Global Hands may benefit from the software because it gave Holdings that money. JIL Sovereign Technologies, Inc. (DE) operates and supports salusagentic.com. JIL Sovereign Technologies, Inc. (DE) operates most, if not all, of the software JIL Sovereign Holdings, LLC (WY) owns. Global Hands, Inc. does not operate this site.

© 2026 JIL Sovereign Technologies, Inc. All rights reserved.